Spbniivs will Fund research of a vaccine against Haemophilus influenzae
Saint-Petersburg Institute of vaccines and serums FMBA Russia (Spbniivs) will be spent 97 million rubles for the conduct of clinical trials of vaccines to prevent infections caused by Haemophilus influenzae.
“The organization and conduct of efficacy and safety of vaccines for prevention of Haemophilus influenzae Baby-Hib, lyophilisate for solution preparation for intramuscular injection, 0.5 ml in the framework of the phase II clinical study involving healthy volunteers 3 months. – 5 years, the initial price of the contract is 97 million rubles,” – writes TASS with reference to the materials of bids for state procurement.
Vaccine Baby-Hib develops Spbniivs. Stated in the competition period of the clinical trials of 448 days from the date of signing of the contract.
